💊USTR Seeks Comments on Foreign Nations Impacting Pharma Innovation
Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation
Summary
Pursuant to the Executive Order titled Delivering Most- Favored-Nation Prescription Drug Pricing to American Patients, USTR invites comments from interested parties regarding any act, policy, or practice that may be unreasonable or discriminatory and that has the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market value in foreign countries.
Agencies
- Trade Representative
- Office of United States
Business Impact
$$$ - High
The text outlines a request for comments regarding foreign nations' unfair practices in the pharmaceutical sector, which could impact pricing, market access, and competitiveness for U.S. businesses. The emphasis on ensuring American patients don't subsidize global R&D could influence trade policies relevant to businesses in the healthcare and pharmaceutical industries.